查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881800

融合切片市場－全球產業規模、佔有率、趨勢、機會及預測，依切片途徑（經直腸、經會陰）、最終用戶（醫院、診斷中心、門診中心）、區域及競爭格局分類，2020-2030年預測

Fusion Biopsy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Biopsy Route (Transrectal, Transperineal), By End-User (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region, Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球融合切片市場規模為6.1892億美元，預計2030年將以8.6%的複合年成長率成長至10.1534億美元。融合活體組織切片是一種先進的診斷技術，它將磁振造影與即時超音波結合，能夠精準定位可疑病灶進行組織取樣，主要用於前列腺部位。此方法透過引導活體組織切片針到達特定異常區域，顯著提高了診斷準確性，優於傳統的隨機取樣。前列腺癌在全球範圍內日益成長的發病率以及影像技術的不斷進步（提高了檢測率和手術精度）是推動融合活體組織切片市場發展的主要因素。

市場概覽
預測期 2026-2030
2024年市場規模 6.1892億美元
2030年市場規模 10.1534億美元
2025-2030年複合年成長率 8.6%
成長最快的細分市場 經直腸
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球融合切片市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 經由切片途徑（經直腸、經會陰）
    • 依最終使用者（醫院、診斷中心、門診中心）分類
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美融合切片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲融合切片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區融合切片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲融合活體組織切片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲融合切片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球融合切片市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Eigen Health Ltd
  • Koninklijke Philips NV
  • Hitachi, Ltd.
  • MedCom Inc
  • Esaoate SpA
  • KOELIS SAS
  • Focal Healthcare Inc
  • UC-Care Medical Systems Ltd.
  • GeoScan Medical

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 21001

The Global Fusion Biopsy Market, valued at USD 618.92 Million in 2024, is projected to experience a CAGR of 8.6% to reach USD 1015.34 Million by 2030. Fusion biopsy is an advanced diagnostic technique that integrates magnetic resonance imaging with real-time ultrasound to precisely target suspicious lesions for tissue sampling, predominantly within the prostate. This method enhances diagnostic accuracy by guiding the biopsy needle to specific abnormal areas, a considerable improvement over traditional random sampling. The market for fusion biopsy is significantly driven by the increasing global prevalence of prostate cancer and continuous advancements in imaging technologies that improve detection and procedural precision.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 618.92 Million
Market Size 2030USD 1015.34 Million
CAGR 2025-20308.6%
Fastest Growing SegmentTransrectal
Largest MarketNorth America

Key Market Drivers

The increasing global prevalence of prostate cancer is a primary market driver, fueling demand for precise diagnostic tools. With new diagnoses consistently rising, advanced detection methods are critical for improved patient outcomes. According to the International Agency for Research on Cancer's Global Cancer Observatory, in 2022, approximately 1.5 million new cases of prostate cancer were reported globally, underscoring this persistent demand. Simultaneously, continuous advancements in medical imaging technologies significantly impact market expansion. Improvements in MRI and ultrasound systems, with sophisticated software, enhance fusion biopsy precision. These technological evolutions enable more accurate lesion identification.

Key Market Challenges

The elevated cost associated with fusion biopsy systems and procedures, alongside challenges in securing comprehensive reimbursement, significantly impedes market expansion. The high capital investment required for these advanced diagnostic platforms creates a substantial financial burden for healthcare providers. This limitation particularly affects institutions with restricted budgets and healthcare systems in developing economies, curtailing their ability to acquire and implement fusion biopsy technology.

Key Market Trends

The integration of Artificial Intelligence and Machine Learning is a significant trend transforming the global fusion biopsy market by enhancing diagnostic accuracy and procedural efficiency. AI algorithms analyze complex imaging data, such as MRI, to identify suspicious lesions with greater precision, reducing inter-operator variability and potentially lowering healthcare costs. This technological advancement also facilitates more efficient workflows, with AI systems capable of optimizing lesion segmentation and image texture analysis.

Key Market Players

  • Eigen Health Ltd
  • Koninklijke Philips N.V.
  • Hitachi, Ltd.
  • MedCom Inc
  • Esaoate SpA
  • KOELIS SAS
  • Focal Healthcare Inc
  • UC-Care Medical Systems Ltd.
  • GeoScan Medical

Report Scope:

In this report, the Global Fusion Biopsy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fusion Biopsy Market, By Biopsy Route:

  • Transrectal
  • Transperineal

Fusion Biopsy Market, By End-User:

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Care Centers

Fusion Biopsy Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Fusion Biopsy Market.

Available Customizations:

Global Fusion Biopsy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fusion Biopsy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Biopsy Route (Transrectal, Transperineal)
    • 5.2.2. By End-User (Hospitals, Diagnostic Centers, Ambulatory Care Centers)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Fusion Biopsy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Biopsy Route
    • 6.2.2. By End-User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Fusion Biopsy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Biopsy Route
        • 6.3.1.2.2. By End-User
    • 6.3.2. Canada Fusion Biopsy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Biopsy Route
        • 6.3.2.2.2. By End-User
    • 6.3.3. Mexico Fusion Biopsy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Biopsy Route
        • 6.3.3.2.2. By End-User

7. Europe Fusion Biopsy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Biopsy Route
    • 7.2.2. By End-User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Fusion Biopsy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Biopsy Route
        • 7.3.1.2.2. By End-User
    • 7.3.2. France Fusion Biopsy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Biopsy Route
        • 7.3.2.2.2. By End-User
    • 7.3.3. United Kingdom Fusion Biopsy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Biopsy Route
        • 7.3.3.2.2. By End-User
    • 7.3.4. Italy Fusion Biopsy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Biopsy Route
        • 7.3.4.2.2. By End-User
    • 7.3.5. Spain Fusion Biopsy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Biopsy Route
        • 7.3.5.2.2. By End-User

8. Asia Pacific Fusion Biopsy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Biopsy Route
    • 8.2.2. By End-User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Fusion Biopsy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Biopsy Route
        • 8.3.1.2.2. By End-User
    • 8.3.2. India Fusion Biopsy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Biopsy Route
        • 8.3.2.2.2. By End-User
    • 8.3.3. Japan Fusion Biopsy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Biopsy Route
        • 8.3.3.2.2. By End-User
    • 8.3.4. South Korea Fusion Biopsy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Biopsy Route
        • 8.3.4.2.2. By End-User
    • 8.3.5. Australia Fusion Biopsy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Biopsy Route
        • 8.3.5.2.2. By End-User

9. Middle East & Africa Fusion Biopsy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Biopsy Route
    • 9.2.2. By End-User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Fusion Biopsy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Biopsy Route
        • 9.3.1.2.2. By End-User
    • 9.3.2. UAE Fusion Biopsy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Biopsy Route
        • 9.3.2.2.2. By End-User
    • 9.3.3. South Africa Fusion Biopsy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Biopsy Route
        • 9.3.3.2.2. By End-User

10. South America Fusion Biopsy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Biopsy Route
    • 10.2.2. By End-User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Fusion Biopsy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Biopsy Route
        • 10.3.1.2.2. By End-User
    • 10.3.2. Colombia Fusion Biopsy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Biopsy Route
        • 10.3.2.2.2. By End-User
    • 10.3.3. Argentina Fusion Biopsy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Biopsy Route
        • 10.3.3.2.2. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Fusion Biopsy Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Eigen Health Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Koninklijke Philips N.V.
  • 15.3. Hitachi, Ltd.
  • 15.4. MedCom Inc
  • 15.5. Esaoate SpA
  • 15.6. KOELIS SAS
  • 15.7. Focal Healthcare Inc
  • 15.8. UC-Care Medical Systems Ltd.
  • 15.9. GeoScan Medical

16. Strategic Recommendations

17. About Us & Disclaimer